- Research article
- Open Access
- Open Peer Review
The usefulness of bone SPECT/CT imaging with volume of interest analysis in early axial spondyloarthritis
BMC Musculoskeletal Disorders volume 16, Article number: 9 (2015)
The role of conventional bone scintigraphy in diagnosing early axial spondyloarthritis (SpA) is yet controversial. Single positron emission computed tomography (SPECT) plus CT is an imaging modality that adds better anatomical information to scintigraphy of the sacroiliac (SI) joint. Our aim was to investigate the usefulness of bone SPECT/CT with volume of interest (VOI) analysis in early axial SpA patients.
Twenty patients (male: female ratio = 12:8; age range = 17–65 years) presenting with inflammatory back pain meeting the Amor criteria of early axial SpA were recruited from a single center in South Korea. Bone scintigraphy was performed 180 min after intravenous injection of 1110 MBq of Tc-99 m-HDP, followed by bone SPECT/CT. The ratio between the entire SI joint and sacrum (SIS ratio) was measured by both bone SPECT/CT and bone scintigraphy. Data from 13 controls were also evaluated. Receiver operating characteristic (ROC) curve was plotted for further analysis, and the correlation between the SIS ratio and SI joint grade by plain radiography was assessed.
The SIS ratio of early axial SpA patients vs. control subjects was significantly increased in bone SPECT/CT (p < 0.001). However, no significant difference was detected in bone scintigraphy. ROC curve analysis showed a significant difference in the area under curve (AUC) of bone SPECT/CT vs. bone scintigraphy (0.862 vs. 0.523, respectively; p < 0.001). With a cut-off SIS ratio of 1.50, ROC curve analysis showed a sensitivity of 80.0% and specificity of 84.6% in bone SPECT/CT. The SIS ratio measured in SPECT/CT, but not that measured in bone scintigraphy, was significantly increased with a higher grade of SI joint changes in plain radiography (p = 0.014).
Bone SPECT/CT is more useful than conventional bone scintigraphy in identifying sacroiliitis in early axial SpA patients, even with mild SI joint changes in plain radiography. By combining CT, we can accurately delineate the sacrum and SI joint uptake with our VOI method.
Axial spondyloarthritis (SpA) is one of the important causes of inflammatory back pain. Axial SpA involves the axial spine, particularly the sacroiliac (SI) joint and is known to be associated with HLA-B27 . Ankylosing spondylitis (AS), the key disease entity of axial SpA, is the most well known, late form of axial SpA with radiographic change. Of note, detection of sacroiliitis by imaging studies is important in diagnosing AS . Plain radiography has been the mainstay imaging modality for AS and is also essential for evaluating disease progression [3,4]. The early form of axial SpA (early axial SpA) is an axial SpA without plain radiographic change and diagnosed by clinical characteristics or magnetic resonance imaging (MRI). Recently, new treatment option (TNF-α therapy, etc.) for axial SpA necessitate early detection of early axial SpA .
Bone scintigraphy also has been used for assessing sacroiliitis. The SI joint to sacrum uptake ratio [sacroiliac joint/sacrum (SIS) ratio] can be measured from the scan: an increased SIS ratio is found mostly in AS patients compared with healthy controls [6,7]. Prominent SI joint uptake and the increased SIS ratio in bone scintigraphy generally portray an advanced stage of sacroiliitis. However, the SIS ratio measured in bone scintigraphy uses a rectangular region of interest that does not represent the accurate uptake of the SI joint and sacrum . Previous studies have tackled the possible limitation of conventional bone scintigraphy in detecting the early manifestations of axial SpA [9-12].
Computed tomography (CT) has been validated for the diagnosis of axial SpA, especially when there are structural changes in the SI joint [13,14]. Recently, magnetic resonance imaging (MRI) has been incorporated as an imaging tool for the new assessment of spondyloarthritis international society (ASAS) classification criteria of axial SpA [15-19]. The ASAS/OMERACT MRI group has recently published definitions of MRI findings in axial SpA. In general, MRI is a useful imaging tool to demonstrate bone marrow edema, osteitis, and enthesitis; however, the cost or accessibility of MRI can become a limiting factor.
In recent years, single positron emission computed tomography (SPECT)/CT has been used in various fields in medicine for functional and anatomical imaging ; SPECT/CT increased specificity compared with SPECT in clinical practice by conjoining the anatomical information provided by CT [21,22]. Compared with conventional bone scintigraphy, SPECT/CT can exclude physiological uptake and better characterize equivocal lesions . In the musculoskeletal field, SPECT/CT can help delineate changes of bone adjacent to the synovial surface. Bone SPECT was shown to be superior to bone scintigraphy in measuring the SIS ratio ; thus, the fusion of SPECT and CT may further provide useful information in detecting early sacroiliitis . To date, no study exists regarding bone SPECT/CT findings in early axial SpA.
In this study, we investigated the characteristics of bone SPECT/CT imaging with volume of interest (VOI) analysis in early axial SpA patients, comparing the findings with those observed in bone scintigraphy and plain radiography.
Between March 2011 and December 2012, 20 patients with inflammatory back pain (IBP) meeting the Amor criteria for SpA (range: 5–10) yet with minimal or no change in the SI joint in plain radiography were prospectively enrolled at the Seoul Metropolitan Government-Seoul National University Hospital Boramae Medical center (SMG-SNU Boramae Medical center) . Patients met four or more of the following five criteria of IBP: improvement with exercise, pain at night, insidious onset, age at onset < 40 years, and no improvement with rest . Symptom onset had to be less than 5 years. As a control group, 13 individuals with mechanical hip or back pain, no history of trauma or injury in the area of interest, and no abnormal findings in plain radiography were included. The patients involved in our study underwent bone scintigraphy and bone SPECT/CT for purpose of research. Written informed consent for participation in this study was obtained from participants. This study was approved by the Institutional Review Board of SMG-SNU Boramae Medical center.
Bone scintigraphy and bone SPECT/CT acquisition
Bone scintigraphy was performed 3 hours after injection of 1110 MBq (30 mCi) Tc-99 m-hydroxy-diphosphonate (HDP). Next, we obtained bone SPECT/CT images using the Hawkeye 4 system (GE Healthcare, Milwaukee, WI, USA); low-dose CT and SPECT images were acquired in turn for 10 and 20 min, respectively. CT images were obtained using 5.0 mm slices and 512 × 512 matrices with a standard filter (140 kV, 2.5 mA). SPECT images were acquired using a 1.5X zoom, 128 × 128 matrices, and a step–and-shoot scan mode. Fusion of CT and SPECT images was performed automatically using intrinsic software.
Analysis of sacroiliac joint lesions
The SIS ratio was measured by both bone scintigraphy and bone SPECT/CT. For bone scintigraphy, rectangular regions of interest (ROIs) were drawn on both SI joints and the sacrum from the posterior planar image. The mean uptake was used to estimate the SIS ratio in bone scintigraphy .
In SPECT/CT, the VOI was used to measure the uptake in both SI joints and the sacrum. VOI was defined using CT images of SPECT/CT. SI joint was defined by the space between sacrum and iliac bone from the start to end of the SI joint. The VOI of the SI joint was defined by the surface of iliac bone and sacrum, the shortest line between the edge of iliac bone and sacrum on each transaxial CT image (Figure 1a). VOI of the sacrum was defined by the bone margin from the start to end of the sacrum on each transaxial CT images (Figure 1b). Each VOI was reconstructed three-dimensionally. After determining the VOI of the SI joint (Figure 1c) and sacrum (Figure 1d), the mean uptake of each VOI in SPECT was used to calculate the SIS ratio. Two individuals performed the VOI measurement of SI joints twice for reproducibility.
In plain radiography, the degree of sacroiliitis was graded according to a 5-point grading system (0 = normal, 1 = suspicious, 2 = sclerosis and some erosions, 3 = severe erosions, widening of the joint space and some ankylosis, 4 = complete ankylosis) . Plain film image was analyzed by two radiologists specialized in musculoskeletal radiology, who were blinded to patient’s clinical findings. The final report with which both radiologists concurred was used in this study.
First, we compared the clinical characteristics and laboratory tests between early axial SpA patients and control subjects. Continuous parameters (age when diagnosis was made, age of symptom onset, symptom duration, body mass index [BMI], erythrocyte sedimentation rate [ESR], C-reactive protein [CRP]) were analyzed by Mann–Whitney U test, and categorical parameters (gender ratio, HLA-B27, peripheral arthritis, enthesitis, uveitis, family history of SpA) were studied by Fisher’s exact test. Reproducibility test was performed for bone SPECT/CT VOI analysis using intra-class correlations (ICC) and coefficients of variation (CV). And the SIS ratio of bone scintigraphy and bone SPECT/CT between early axial SpA patients and controls was compared using Mann–Whitney U test. Receiver operating characteristic (ROC) curve analysis was performed for bone scintigraphy and bone SPECT/CT, along with area under the curve (AUC), cut-off value, sensitivity, and specificity of each modality. Lastly, Kruskal-Wallis test was used to compare the SIS ratio of bone SPECT/CT among different grades of sacroiliitis in plain radiography. All statistical analyses were lesion based and performed using SPSS software (ver. 18.0; SPSS Inc., Chicago, IL, USA) and MedCalc (MedCalc Inc., Mariakerke, Belgium). A p-value less than 0.05 was deemed to indicate statistical significance.
The mean age of the 20 early axial SpA patients was 35.3 ± 12.5 years (male: female ratio = 12:8, age range = 17–65 years). The mean age of symptom onset was 33.2 ± 13.5 years (age range = 10–65 years), and the mean symptom duration was 24.0 ± 18.4 months (range = 1–60 months). No significant difference was noted in age, age of symptom onset, symptom duration and BMI between axial SpA patients and control subjects. Early axial SpA patients showed significant positive symptoms of HLA-B27 (p = 0.002), and peripheral arthritis (p = 0.002), and increased ESR (p = 0.032) and CRP (p = 0.004) compared with control subjects. Other parameters showed no significant change (Table 1).
Reproducibility of bone SPECT/CT VOI analysis
ICC and %CV of bone SPECT/CT VOI analysis were 0.814 (range = 0.696-0.886, p < 0.001) and 5.6%, respectively, which demonstrates reliable reproducibility.
Comparison of the SIS ratio between early axial SpA patients and control subjects
A significant increase in the SIS ratio was observed in early axial SpA patients compared with control subjects by bone SPECT/CT (1.68 ± 0.29 vs. 1.43 ± 0.14, respectively; p < 0.001). However, no significant difference in the SIS ratio was found between early axial SpA patients and control subjects by bone scintigraphy (1.10 ± 0.21 vs. 1.12 ± 0.17, respectively; p = 0.916) (Figures 2 and 3).
ROC curve analysis of the SIS ratio in bone SPECT/CT and bone scintigraphy
ROC curve analysis showed an AUC of 0.862 by bone SPECT/CT [95% confidence interval (CI) = 0.736 – 0.987; p < 0.001] and 0.523 by bone scintigraphy (95% CI = 0.310 – 0.737; p = 0.832). The ROC curves of the two imaging modalities were significantly different (p < 0.001). Bone SPECT/CT revealed a sensitivity of 80.0% and specificity of 84.6% with an SIS ratio cut-off value of 1.50, whereas bone scintigraphy showed a sensitivity of 65.0% and specificity of 53.9% with a cut-off value of 1.08 (Figure 4).
Analysis of the SIS ratio of bone SPECT/CT according to plain radiography
A total of 40 SI joints of early axial SpA patients were graded by plain radiography. The number of SI joints with a grade of 0, 1, or 2 was 15, 18, or 7, respectively. The SIS ratio of bone SPECT/CT increased in grade 1 or 2 of sacroiliitis than grade 0 of plain radiography (grade 0 = 1.54 ± 0.18, grade 1 = 1.80 ± 0.31, and grade 2 = 1.81 ± 0.19, p = 0.007). Statistically significant group difference was found between grade 0 vs. grade 1 and grade 0 vs. grade 2 of plain radiography in post hoc analysis In bone scintigraphy, no significant difference in the SIS ratio among sacroiliitis grades was identified (p = 0.065) (Table 2).
Plain radiography has been the mainstay of SI joint imaging; however, this modality is mainly useful in identifying advanced stages of axial SpA, usually AS. In addition, CT alone is an imperfect imaging modality for diagnosing active sacroiliitis . In the present study, we investigated the usefulness of bone SPECT/CT with VOI analysis for early axial SpA, the early stage of the axial SpA. We demonstrated that bone SPECT/CT is advantageous over conventional bone scintigraphy in detecting sacroiliitis. With the findings of CT, bone SPECT/CT not only can better delineate the anatomy and joint damage but also can identify the volume of the SI joint and sacrum, leading to a better estimation of the SIS ratio. As we used same radiotracer for bone scintigraphy and bone SPECT/CT image acquisition (Tc-99 m-HDP) with one injection of radiotracer, there is no further radiation due to SPECT image acquisition. Furthermore, CT of SPECT/CT scanner of this study is combined low-dose CT which could minimize the radiation exposure by CT to the patient.
Tc-99 m-HDP is specifically absorbed to the bone, and the radiotracer uptake depends on local blood flow and rate of extraction of the bone . The bony changes of early SpA in the axial bone can induce increased Tc-99 m-HDP uptake and can be identified by SPECT/CT. To prove this, we introduced a new method of SIS ratio measurement in SPECT/CT with the mean uptake in a pre-defined volume of the SI joint and sacrum. Previous studies in the nuclear medicine field had some drawbacks in quantifying the SIS ratio due to overlapping of the adjacent structures without a definite demarcation of the bony structure . Some papers have insisted the usefulness of early detection of AS by bone scintigraphy [31,32] or SPECT alone ; however, their conclusions are not commonly accepted, and shows limited value for diagnosing probable or suspected AS as well as established AS . SPECT offers more information than planar imaging of the SI joint; however, accurate delineation of the SI joint or sacrum is nearly impossible. SPECT/CT provides much more precise information and resolution of the area of interest than planar imaging obtained by bone scintigraphy and SPECT. Furthermore, using the CT image for delineating the sacrum and SI joint decreased the inter-observer variation.
As our aim was to investigate the difference in the SIS ratio between SPECT/CT and bone scintigraphy in early axial SpA, ROC curve analysis of both bone SPECT/CT and bone scintigraphy was performed to predict the best cut-off value to aid in the diagnosis of early axial SpA. A SIS ratio greater than 1.50 by SPECT/CT demonstrated the best sensitivity (80.0%) and specificity (84.6%). In fact, the optimal cut-off value of the SIS ratio may differ depending on the radiopharmaceutical and imaging modality. For instance, a SIS ratio greater than 1.2 has been commonly observed in patients with sacroiliitis in conventional bone scintigraphy. A recent study showed a SIS ratio cut-off value of 1.3 for F-18-fluoride PET-CT in AS . Another study report that F-18-fluoride PET/CT, the bone turnover radiotracer, was useful to diagnose ankylosing spondylitis, while F-18-FDG PET/CT was not . We hypothesized that Tc-99 m-HDP is also the bone turnover agent like F-18-fluoride, it reflected early SpA well, and expect it can be used with lower cost and availability compared with F-18-fluoride PET/CT.
Notably, SPECT/CT was able to differentiate the subtle changes of sacroiliitis by plain radiography (grade 0 vs. grade 1 or 2), in contrast to bone scintigraphy. Previous studies have shown that the SIS ratio in bone scintigraphy is greater in advanced SI joint lesions by plain radiography . However, this finding was only appreciated in sacroiliitis of grade 3 or higher; in other words, AS, the late form of axial SpA . All 20 axial SpA patients in our study met the Amor criteria without evident plain radiography findings (early axial SpA; less than grade 2). Thus, our data indicate that bone SPECT/CT is more useful in identifying early changes in the SI joint compared with conventional bone scintigraphy.
There are several limitations in our study. First, this study consists of relatively small number of early axial SpA patients. As the purpose of our study was to specifically demonstrate the bone SPECT/CT SI joint findings in early SpA patients, we did not obtained clinical data associated with disease activity, such as Bath ankylosing spondylitis disease activity index (BASDAI) or patient’s global assessment. In addition, MRI comparison data for diagnosis of early axial SpA, and predicting and monitoring treatment response using bone SPECT/CT needs to be evaluated in the future . We are planning a prospective comparative study using bone SPECT/CT, F-18-fluoride PET/CT  and MRI [38,39] for the diagnosis of early axial SpA with long-term follow up. Lastly, advantages of follow-up imaging with SPECT/CT would be need to be weighed against repeated radiation exposure and should be considered carefully.
The SIS ratio obtained by bone SPECT/CT, is more useful than conventional bone scintigraphy or plain radiography in diagnosing early axial SpA. Low-dose CT adds structural information and helps detailed VOI information of the SI joint and sacrum. We propose 1.50 as the cut-off SIS ratio to consider for the diagnosis of early axial SpA by bone SPECT/CT.
Single positron emission computed tomography
Volume of interest
- SIS ratio:
Ratio between the entire SI joint and sacrum
Erythrocyte sedimentation rate
Coefficients of variation
Reciever operating characteristic
Area under curve
Magnetic resonance imaging
Assessment of spondyloarthritis international society
Bath’s ankylosing spondylitis disease activity index
Merrick MV. Investigation of joint disease. Eur J Nucl Med. 1992;19(10):894–901.
Braun J, Sieper J. Early diagnosis of spondyloarthritis. Nat Clin Pract Rheumatol. 2006;2(10):536–45.
van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361–8.
Maksymowych WP, Landewe R. Imaging in ankylosing spondylitis. Best Pract Res Clin Rheumatol. 2006;20(3):507–19.
Inman RD, Clegg DO, Davis JC, Whitmore JB, Solinger A. Etanercept in adult patients with early onset ankylosing spondylitis. J Rheumatol. 2006;33:1634–6.
Namey TC, McIntyre J, Buse M, LeRoy EC. Nucleographic studies of axial spondarthritides. I. Quantitative sacroiliac scintigraphy in early HLA-B27-associated sacroiliitis. Arthritis Rheum. 1977;20(5):1058–64.
Miron SD, Khan MA, Wiesen EJ, Kushner I, Bellon EM. The value of quantitative sacroiliac scintigraphy in detection of sacroiliitis. Clin Rheumatol. 1983;2(4):407–14.
Song IH, Carrasco-Fernandez J, Rudwaleit M, Sieper J. The diagnostic value of scintigraphy in assessing sacroiliitis in ankylosing spondylitis: a systematic literature research. Ann Rheum Dis. 2008;67(11):1535–40.
Braun J, Baraliakos X. Imaging of axial spondyloarthritis including ankylosing spondylitis. Ann Rheum Dis. 2011;70 Suppl 1:i97–103.
Brandt HC, Spiller I, Song IH, Vahldiek JL, Rudwaleit M, Sieper J. Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis. Ann Rheum Dis. 2007;66(11):1479–84.
Kjallman M, Nylen O, Hansen M. Evaluation of quantitative sacro-iliac scintigraphy in the early diagnosis of ankylosing spondylitis. Scand J Rheumatol. 1986;15(3):265–71.
Diffey BL, Pal B, Gibson CJ, Clayton CB, Griffiths ID. Application of Bayes’ theorem to the diagnosis of ankylosing spondylitis from radioisotope bone scans. Ann Rheum Dis. 1985;44(10):667–70.
Fam AG, Rubenstein JD, Chin-Sang H, Leung FY. Computed tomography in the diagnosis of early ankylosing spondylitis. Arthritis Rheum. 1985;28(8):930–7.
Carrera GF, Foley WD, Kozin F, Ryan L, Lawson TL. CT of sacroiliitis. AJR Am J Roentgenol. 1981;136(1):41–6.
Rudwaleit M, Jurik AG, Hermann KG, Landewe R, van der Heijde D, Baraliakos X, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis. 2009;68(10):1520–7.
Colbert RA. Early axial spondyloarthritis. Curr Opin Rheumatol. 2010;22(5):603–7.
Rudwaleit M, Feldtkeller E, Sieper J. Easy assessment of axial spondyloarthritis (early ankylosing spondylitis) at the bedside. Ann Rheum Dis. 2006;65(9):1251–2.
Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthritis early. Ann Rheum Dis. 2004;63(5):535–43.
Weber U, Maksymowych WP. Sensitivity and specificity of magnetic resonance imaging for axial spondyloarthritis. Am J Med Sci. 2011;341(4):272–7.
Bybel B, Brunken RC, DiFilippo FP, Neumann DR, Wu G, Cerqueira MD. SPECT/CT imaging: clinical utility of an emerging technology. Radiographics. 2008;28(4):1097–113.
Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, et al. SPECT/CT. J Nucl Med. 2008;49(8):1305–19.
Y-i K, Jung YH, Hwang KT, Lee H-Y. Efficacy of 99mTc-sestamibi SPECT/CT for minimally invasive parathyroidectomy: comparative study with 99mTc-sestamibi scintigraphy, SPECT, US and CT. Ann Nucl Med. 2012;26(10):804–10.
Patel CN, Chowdhury FU, Scarsbrook AF. Hybrid SPECT/CT: the end of “unclear” medicine. Postgrad Med J. 2009;85(1009):606–13.
Jacobsson H, Larsson SA, Vesterskold L, Lindvall N. The application of single photon emission computed tomography to the diagnosis of ankylosing spondylitis of the spine. Br J Radiol. 1984;57(674):133–40.
Willick SE, Kendall RW, Roberts ST, Morton K. An emerging imaging technology to assist in the localization of axial spine pain. PM R. 2009;1(1):89–92.
Amor B, Dougados M, Mijiyawa M. Criteria of the classification of spondylarthropathies. Rev Rhum Mal Osteoartic. 1990;57(2):85–9.
Sieper J, van der Heijde D, Landewe R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009;68(6):784–8.
Braun J, Golder W, Bollow M, Sieper J, van der Heijde D. Imaging and scoring in ankylosing spondylitis. Clin Exp Rheumatol. 2002;20(6 Suppl 28):S178–84.
Battafarano DF, West SG, Rak KM, Fortenbery EJ, Chantelois AE. Comparison of bone scan, computed tomography, and magnetic resonance imaging in the diagnosis of active sacroiliitis. Semin Arthritis Rheum. 1993;23(3):161–76.
Wong KK, Piert M. Dynamic Bone Imaging with 99mTc-Labeled Diphosphonates and 18 F-NaF: Mechanisms and Applications. J Nucl Med. 2013;54(4):590–9.
Collie DA, Smith GW, Merrick MV. 99mTc-MDP scintigraphy in ankylosing spondylitis. Clin Radiol. 1993;48(6):392–7.
Kacar G, Kacar C, Karayalcin B, Gungor F, Tuncer T, Erkilic M. Quantitative sacroiliac joint scintigraphy in normal subjects and patients with sacroiliitis. Ann Nucl Med. 1998;12(3):169–73.
Peh WC, Ho WY, Luk KD. Applications of bone scintigraphy in ankylosing spondylitis. Clin Imaging. 1997;21(1):54–62.
Strobel K, Fischer DR, Tamborrini G, Kyburz D, Stumpe KD, Hesselmann RG, et al. 18 F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis. Eur J Nucl Med Mol Imaging. 2010;37(9):1760–5.
Bruijnen ST, van der Weijden MA, Klein JP, Hoekstra OS, Boellaard R, van Denderen JC, et al. Bone formation rather than inflammation reflects Ankylosing Spondylitis activity on PET-CT: a pilot study. Arthritis Res Ther. 2012;14(2):R71.
Ho Jr G, Sadovnikoff N, Malhotra CM, Claunch BC. Quantitative sacroiliac joint scintigraphy. A critical assessment. Arthritis Rheum. 1979;22(8):837–44.
Baraliakos X, Braun J. Opinion: Perspectives on imaging in axial spondyloarthritis. Nat Rev Rheumatol. 2013;9(8):498–502.
Rudwaleit M, Landewe R, van der Heijde D, Listing J, Brandt J, Braun J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009;68(6):770–6.
Yu W, Feng F, Dion E, Yang H, Jiang M, Genant HK. Comparison of radiography, computed tomography and magnetic resonance imaging in the detection of sacroiliitis accompanying ankylosing spondylitis. Skeletal Radiol. 1998;27(6):311–20.
The authors declare that they have no competing interests.
HYL conceived the project and collected SPECT/CT and bone scintigraphy data. KS conceived the project and collected the clinical data. YK analyzed the data and drafted the manuscript. MS identified and analyzed the data. YKK conceived the project and helped to draft the manuscript. All authors revised and approved the final manuscript.
Ho-Young Lee and Kichul Shin contributed equally to this work.
About this article
Cite this article
Kim, Y., Suh, M., Kim, Y.K. et al. The usefulness of bone SPECT/CT imaging with volume of interest analysis in early axial spondyloarthritis. BMC Musculoskelet Disord 16, 9 (2015) doi:10.1186/s12891-015-0465-x
- Bone scintigraphy
- SIS ratio
- Axial spondyloarthritis